Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology CorporationJanuary 25, 2017 Read More
Emmaus Life Sciences, Inc. Receives Japanese Patent for use of L-glutamine in Treatment of DiverticulosisDecember 13, 2016 Read More
Emmaus Life Sciences Receives Notice of FDA PDUFA Date for Investigational L-glutamine Treatment for Sickle Cell DiseaseNovember 30, 2016 Read More
Emmaus’ New Drug Application for Sickle Cell Disease Accepted for Review by FDANovember 08, 2016 Read More
